Detection of some volatile degradation products released during photoexposition of ranitidine in a solid state

Journal of Pharmaceutical and Biomedical Analysis

Volumn 76, Issue , 2013, Pages 177-182

  Jamrógiewicz, Marzena ^a   Wielgomas, Bartosz ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

GC MS; Photodegradation; Ranitidine hydrochloride; Solid phase microextraction; Stability tests; Volatile products

Indexed keywords

5 DIMETHYLFURFURAL; ACETALDOXIME; N,N DIMETHYLACETAMIDE; N,N DIMETHYLFORMAMIDE; RANITIDINE; THIAZOLE; UNCLASSIFIED DRUG; VOLATILE AGENT;

ARTICLE; GAS CHROMATOGRAPHY; IRRADIATION; MASS SPECTROMETRY; PRIORITY JOURNAL; SOLID STATE;

DRUG STABILITY; DRUG STORAGE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HALF-LIFE; HISTAMINE H2 ANTAGONISTS; PHOTOLYSIS; RANITIDINE; SOLID PHASE MICROEXTRACTION;

EID: 84872472715     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2012.12.019     Document Type: Article

References (28)

1. Isidori M., Parrella A., Pistillo P., Temussi F. Effects of ranitidine and its photoderivatives in the aquatic environment. Environ. Int. 2009, 35:821-825.
2. Williams M.F., Hak L.J., Dukes G. In vitro evaluation of the stability of ranitidine hydrochloride in total parenteral nutrient mixtures. Am. J. Hosp. Pharm. 1990, 47:1574-1579.
3. Vehabovic M., Hadzsovic S., Stambolic F., Hadzic A., Vranjes E., Haracic E. Stability of ranitidine in injectable solution. Int. J. Pharm. 2003, 256:109-115.
4. Guerrieri P., Salameh A.K., Taylor L.S. Effect of small of impurities on the water vapour sorption behaviour of ranitidine HCl. Pharm. Res. 2007, 24:147-156.
5. Teraoka R., Otsuka M., Matsuda Y. Effects of temperature and relative humidity on the solid-state chemical stability of ranitidine hydrochloride. J. Pharm. Sci. 1993, 82:601-604.
6. Haywood P.A., Martin-Smith M., Cholerton T.J. Isolation and identification of the hydrolytic degradation products of ranitidine hydrochloride. J. Chem. Soc. Perkin Trans. 1987, 951-954.
7. Guerrieri P., Smith D.T., Taylor L.S. Phase behavior of ranitidine HCl in the presence of degradants and atmospheric moisture - impact on chemical stability. Langmuir 2008, 24:3850-3856.
8. Castiglioni S., Bagnati R., Calamari D., Fanelli R., Zuccato E. Multiresidue analytical method using solid-phase extraction and high-pressure liquid chromatography tandem mass spectrometry to measure pharmaceuticals of different therapeutic classes in urban wastewaters. J. Chromatogr. A 2005, 1092:206-215.
9. The Pharmaceutical Codex, 1994.
10. Radjenović J., Sirtori C., Petrović M., Barceló D., Malato S. Characterization of intermediate products of solar photocatalytic degradation of ranitidine at pilot-scale. Chemosphere 2010, 79:368-376.
11. Addamo M., Augugliaro V., Di Paola A., García-López E., Loddo V., Marcì G., Palmisano L. Removal of drugs in aqueous systems by photoassisted degradation. J. Appl. Electrochem. 2005, 35:765-774.
12. 2 and a nanofiltration membrane reactor. Catal. Today 2006, 118:205-213.
13. Latch D., Stender B., Packer J., Arnold W., McNeill K. Photochemical fate of pharmaceuticals in the environment: cimetidine and ranitidine. Environ. Sci. Technol. 2003, 37:3342-3350.
14. Gros M., Petrovic M., Barcelo D. Development of a multi-residue analytical methodology based on liquid chromatography-tandem mass spectrometry (LC-MS/MS) for screening and trace level determination of pharmaceuticals in surface and wastewaters. Talanta 2006, 70:678-690.
15. Pikul P., Nowakowska J., Rogulski P. Simple thin-layer chromatographic method for analysis of ranitidine in its pharmaceutical formulations: application to the analysis of photolytic degradation products. J. Planar Chromatogr. Mod. TLC 2010, 23:304-308.
16. Volonte M.G., Yuln G., Mandrille A., Longo R., Cingolani A. Stability of ranitidine tablets subjected to stress and environmental conditions, by HPLC. Boll. Chim. Farm. 2001, 140:316-321.
17. Jamrógiewicz M., Łukasiak J. Short term monitor of photodegradation processes in ranitidine hydrochloride observed by FTIR and ATR-FTIR. J. Food Drug Anal. 2009, 17:342-347.
18. Basak A.K., Raw A.S., Hakim A.H., Furness S., Samaan N., Gill D.S., Patel H.B., Powers R.F., Yu L. Pharmaceutical impurities: regulatory perspective for abbreviated new drug applications. Adv. Drug Del. Rev. 2007, 59:64-72.
19. Ahuja S. Assuring quality of drugs by monitoring impurities. Adv. Drug Del. Rev. 2007, 59:3-11.
20. Albini A., Fasani E. Drugs, Photochemistry and Photostability 1998, Royal Society of Chemistry, Great Britain.
21. Baertschi S.W., Jansen P.J. Stress testing: a predictive tool. Drugs and the Pharmaceutical Sciences, Pharmaceutical Stress Testing 2005, 67-68. Taylor & Francis Group, LLC, Boca Raton. J. Swarbrick (Ed.).
22. Shen R., Andrews S.A. Demonstration of 20 pharmaceuticals and personal care products (PPCPs) as nitrosamine precursors during chloramine disinfection. Water Res. 2011, 45:944-952.
23. Drug Information Online http://www.drugs.com/pro/ranitidine.html.
24. A.F. Sorg, K.H. Valia, A.B. Eoga, D.J. Denick. Ranitidine salts on magnesium trisilicate as an adsorbate. Patent Cooperation Treaty WO 96/39126 (1996).
25. Guidelines on Odour Pollution & Its Control 2008, Central Pollution Control Board, Ministry of Environment & Forest, India. http://cpcb.nic.in/divisionsofheadoffice/pci2/package_odourreport_2.12.08.pdf.
26. ICH: Q1B Guideline, Stability testing: photostability testing of new drug substances and products. Fed. Reg. 1996, 62:27115-27122. (EMEA: Guideline on stability testing: stability testing of existing active substances and related finished products, 2003).
27. B. Alhede, Process for the preparation of ranitidine or acid addition salts thereof, and intermediates for this preparation EP Patent 0,219,225 (1989).
28. Brambilla G., Mattioli F., Martelli A. Genotoxic and carcinogenic effects of gastrointestinal drugs. Mutagenesis 2010, 25:315-326.